Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Magkouta (ATHENS, Greece). MTH-1 inhibition retards mesothelioma progression. 299

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 Effects of mTOR Inhibition in malignant mesothelioma Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Long-term proteasome inhibition promotes chemical lung carcinogenesis Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 The inhibitory effect of PI3k inhibitor and MEK inhibitor on malignant pleural mesothelioma cell growth Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1 Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 IGF1R facilitates implantation and progression of lung metastasis acting in the tumor microenvironment Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Role of inflammation in aerogenous progression of adenocarcinoma Source: Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases Year: 2004 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Alpha1-antitrypsin inhibits staurosporine-induced apoptosis of NSCLC cells Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 PP133 – IGF1R acts in the tumor microenvironment as a cancer-promoting factor facilitating the implantation and progression of lung metastasis Source: ERS Lung Science Conference 2021 Year: 2021 Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 101s Year: 2005 Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019